Evidence map›Paper›PMID 36154446›Full record

ArticleGut microbes

The

Landry L Tsoumtsa Meda, Luce Landraud, Serena Petracchini, Stéphane Descorps-Declere, Emeline Perthame, Marie-Anne Nahori, Laura Ramirez Finn, Molly A Ingersoll, Rafael Patiño-Navarrete, Philippe Glaser and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Research Progress on perinatalFrontiers in microbiology · 2026
    Review
  4. Article
  5. Genomic Characterization ofMicroorganisms · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Strain belonging to an emerging, virulent sublineage of ST131Frontiers in cellular and infection microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Landry L Tsoumtsa MedaInstitut Pasteur, Université Paris Cité, CNRS UMR6047, INSERM U1306, Unité des Toxines Bactériennes, Département de Microbiologie, Paris, France.
Luce LandraudUniversité Paris Cité et Université Sorbonne Paris Nord, INSERM U1137, IAME, Paris, France.
Serena PetracchiniInstitut Pasteur, Université Paris Cité, CNRS UMR6047, INSERM U1306, Unité des Toxines Bactériennes, Département de Microbiologie, Paris, France.
Stéphane Descorps-DeclereInstitut Pasteur, Université Paris Cité, CNRS UMR6047, INSERM U1306, Unité des Toxines Bactériennes, Département de Microbiologie, Paris, France.
Emeline PerthameInstitut Pasteur, Université Paris Cité, Bioinformatics and Biostatistics Hub, Paris, France.
Marie-Anne NahoriInstitut Pasteur, Université Paris Cité, CNRS UMR6047, INSERM U1306, Unité des Toxines Bactériennes, Département de Microbiologie, Paris, France.
Laura Ramirez FinnInstitut Pasteur, Department of Immunology, Mucosal Inflammation and Immunity group, Paris, France.
Molly A IngersollInstitut Pasteur, Department of Immunology, Mucosal Inflammation and Immunity group, Paris, France.
Rafael Patiño-NavarreteInstitut Pasteur, Université Paris Cité, CNRS UMR6047, Unité Ecologie et Evolution de la Résistance aux Antibiotiques, Département de Microbiologie, Paris, France.
Philippe GlaserInstitut Pasteur, Université Paris Cité, CNRS UMR6047, Unité Ecologie et Evolution de la Résistance aux Antibiotiques, Département de Microbiologie, Paris, France.
Richard BonnetUMR INSERM U1071, INRA USC-2018, Université Clermont Auvergne, Clermont-Ferrand, France.
Olivier DussurgetInstitut Pasteur, Université Paris Cité, CNRS UMR6047, Unité de Recherche Yersinia, Département de Microbiologie, Paris, France.
Erick DenamurUniversité Paris Cité et Université Sorbonne Paris Nord, INSERM U1137, IAME, Paris, France.
Amel MettouchiInstitut Pasteur, Université Paris Cité, CNRS UMR6047, INSERM U1306, Unité des Toxines Bactériennes, Département de Microbiologie, Paris, France.ORCID 0000-0003-1453-6482
Emmanuel LemichezInstitut Pasteur, Université Paris Cité, CNRS UMR6047, INSERM U1306, Unité des Toxines Bactériennes, Département de Microbiologie, Paris, France.ORCID 0000-0001-9080-7761

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epidemiological projections point to acquisition of ever-expanding multidrug resistance (MDR) by

Indexed as

Bacterial ToxinsEscherichia coli InfectionsEscherichia coli ProteinsGastrointestinal MicrobiomeAnti-Bacterial Agentsbeta-LactamasesDrug Resistance, Multiple, BacterialEscherichia coliHumansrho GTP-Binding ProteinsVirulence FactorsAnti-Bacterial AgentsBacterial Toxinsbeta-Lactamasescytotoxic necrotizing factor type 1Escherichia coli Proteinsrho GTP-Binding ProteinsVirulence FactorsCNF1colonizationEscherichia coliExPECgastrointestinal tractrho GTPasesST131UTI

Identifiers

PMID36154446
PMCPMC9519008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.